Cargando…
A randomized controlled trial of different serum phosphate ranges in subjects on hemodialysis
BACKGROUND: Hyperphosphataemia in dialysis subjects is associated with increased mortality. However cause and effect has not been proven, and the ideal phosphate target range is unknown despite KDOQI’s call for studies over 12 years ago. The design and conduct of a randomized controlled trial is cha...
Autores principales: | Bhargava, Ramya, Kalra, Philip A., Hann, Mark, Brenchley, Paul, Hurst, Helen, Hutchison, Alastair J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360717/ https://www.ncbi.nlm.nih.gov/pubmed/30717691 http://dx.doi.org/10.1186/s12882-019-1216-2 |
Ejemplares similares
-
A Study to Inform the Design of a National Multicentre Randomised Controlled Trial to Evaluate If Reducing Serum Phosphate to Normal Levels Improves Clinical Outcomes including Mortality, Cardiovascular Events, Bone Pain, or Fracture in Patients on Dialysis
por: Bhargava, Ramya, et al.
Publicado: (2015) -
Analysis of serum phosphate control and phosphate binder utilization in incident hemodialysis patients
por: Farrand, Kimberly F, et al.
Publicado: (2014) -
Encapsulating peritoneal sclerosis following renal transplantation despite tamoxifen and immunosuppressive therapy
por: de Freitas, Declan, et al.
Publicado: (2008) -
Effects of education on low-phosphate diet and phosphate binder intake to control serum phosphate among maintenance hemodialysis patients: A randomized controlled trial
por: Lim, Eunsoo, et al.
Publicado: (2018) -
Phosphate binding therapy in dialysis patients: focus on lanthanum carbonate
por: Mohammed, Ismail A, et al.
Publicado: (2008)